Showing posts with label Interval Cancers. Show all posts
Showing posts with label Interval Cancers. Show all posts

Thursday, 9 October 2008

Breast screening: Axillary lymph node status of interval cancers by interval year

Breast screening: Axillary lymph node status of interval cancers by interval year
Lauro Bucchi, Donella Puliti, Alessandra Ravaioli, Laura Cortesi, Vincenzo De Lisi, Fabio Falcini, Stefano Ferretti, Alfonso Frigerio, Lucia Mangone, Marco Petrella, Chiara Petrucci, Priscilla Sassoli de Bianchi, Adele Traina, Rosario Tumino, Roberto Zanetti, Manuel Zorzi, Eugenio Paci
The Breast 17 (2008) 477 - 483

Link to journal

We can confirm the hypothesis that there exists a relationship between the time since last negative screen and the biological aggressiveness of interval-surfacing cancers. The second interval year, but not the first, was associated with an excess risk of lymph node metastases that was independent from tumour size and grade. The results of this study improve the understanding of the screening process, particularly the interplay between mammography sensitivity and the natural history of breast cancer.

Sunday, 2 December 2007

Interval breast cancers in screening: The effect of mammography review method on classification

Interval breast cancers in screening: The effect of mammography review method on classification
Stefano Ciatto, Sandra Catarzi, Maria Perla Lamberini, Gabriella Risso, Gianni Saguatti, Teresa Abbattista, Francesca Martinelli and Nehmat Houssami
The Breast 16, Issue 6, December 2007, Pages 646-652

More ‘informed’ review is more likely to yield an IC classification as MS or SE. Due to expected variability, review methods need standardisation to improve screening quality. Our data support blinded review of IC in mammography screening.